Prostate Cancer, Prostate Cancer Death, and Death From Other Causes, Among Men With Metabolic Aberrations

Epidemiology. 2014 Nov;25(6):823-8. doi: 10.1097/EDE.0000000000000174.

Abstract

Background: Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prostate cancer. The aim of this study was to calculate, in a real-life scenario, the risk of prostate cancer diagnosis, prostate cancer death, and death from other causes.

Methods: In the Metabolic Syndrome and Cancer Project, prospective data on body mass index, blood pressure, glucose, cholesterol, and triglycerides were collected from 285,040 men. Risks of prostate cancer diagnosis, prostate cancer death, and death from other causes were calculated by use of competing risk analysis for men with normal (bottom 84%) and high (top 16%) levels of each factor, and a composite score.

Results: During a mean follow-up period of 12 years, 5,893 men were diagnosed with prostate cancer, 1,013 died of prostate cancer, and 26,328 died of other causes. After 1996, when prostate-specific antigen testing was introduced, men up to age 80 years with normal metabolic levels had 13% risk of prostate cancer, 2% risk of prostate cancer death, and 30% risk of death from other causes, whereas men with metabolic aberrations had corresponding risks of 11%, 2%, and 44%.

Conclusions: In contrast to recent studies using conventional survival analysis, in a real-world scenario taking risk of competing events into account, men with metabolic aberrations had lower risk of prostate cancer diagnosis, similar risk of prostate cancer death, and substantially higher risk of death from other causes compared with men who had normal metabolic levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Austria / epidemiology
  • Biomarkers, Tumor / blood
  • Blood Glucose / analysis
  • Blood Pressure
  • Body Mass Index
  • Cause of Death
  • Cholesterol / blood
  • Humans
  • Male
  • Middle Aged
  • Norway / epidemiology
  • Prospective Studies
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / mortality*
  • Registries
  • Risk Factors
  • Surveys and Questionnaires
  • Survival Analysis
  • Sweden / epidemiology
  • Triglycerides / blood

Substances

  • Biomarkers, Tumor
  • Blood Glucose
  • Triglycerides
  • Cholesterol
  • Prostate-Specific Antigen